Paper36925703
Biomimetic cell membrane-coated poly(lactic-co-glycolic acid) nanoparticles for biomedical applications.
Jan N and 10 others. Bioeng Transl Med, 2023. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Biomimetic cell membrane-coated poly(lactic-co-glycolic acid) nanoparticles for biomedical applications. Papers, record 36925703. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36925703
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biomimetic cell membrane-coated poly(lactic-co-glycolic acid) nanoparticles for biomedical applications.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References254
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32546174 | Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy. | J Nanobiotechnology | 2020 | https://conductscience.org/library/papers/32546174 | PubMed |
| 2 | 28631779 | Recent advances in nanomedicines for the treatment of rheumatoid arthritis. | Biomater Sci | 2017 | https://conductscience.org/library/papers/28631779 | PubMed |
| 3 | 19435455 | Current advances in research and clinical applications of PLGA-based nanotechnology. | Expert Rev Mol Diagn | 2009 | https://conductscience.org/library/papers/19435455 | PubMed |
| 4 | 31753395 | Covalent immobilization of biomolecules on stent materials through mussel adhesive protein coating to form biofunctional films. | Mater Sci Eng C Mater Biol Appl | 2020 | https://conductscience.org/library/papers/31753395 | PubMed |
| 5 | 36176622 | Integrated bioactive scaffold with aptamer-targeted stem cell recruitment and growth factor-induced pro-differentiation effects for anisotropic meniscal regeneration. | Bioeng Transl Med | 2022 | https://conductscience.org/library/papers/36176622 | PubMed |
| 6 | 25543006 | Non-genetic engineering of cells for drug delivery and cell-based therapy. | Adv Drug Deliv Rev | 2015 | https://conductscience.org/library/papers/25543006 | PubMed |
| 7 | 31193785 | Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma. | Acta Pharm Sin B | 2019 | https://conductscience.org/library/papers/31193785 | PubMed |
| 8 | 19179312 | Antibiotic-resistant bugs in the 21st century--a clinical super-challenge. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19179312 | PubMed |
| 9 | 17267386 | Resolution of inflammation: state of the art, definitions and terms. | FASEB J | 2007 | https://conductscience.org/library/papers/17267386 | PubMed |
| 10 | 33748672 | Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19). | Emergent Mater | 2021 | https://conductscience.org/library/papers/33748672 | PubMed |
| 11 | 30444351 | Cell-Membrane Immunotherapy Based on Natural Killer Cell Membrane Coated Nanoparticles for the Effective Inhibition of Primary and Abscopal Tumor Growth. | ACS Nano | 2018 | https://conductscience.org/library/papers/30444351 | PubMed |
| 12 | 29577477 | Neutrophil-Based Drug Delivery Systems. | Adv Mater | 2018 | https://conductscience.org/library/papers/29577477 | PubMed |
| 13 | 30895453 | PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution. | Drug Deliv Transl Res | 2019 | https://conductscience.org/library/papers/30895453 | PubMed |
| 14 | 25587657 | Understanding HIV latency: the road to an HIV cure. | Annu Rev Med | 2015 | https://conductscience.org/library/papers/25587657 | PubMed |
| 15 | 27626769 | Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus. | Adv Mater | 2016 | https://conductscience.org/library/papers/27626769 | PubMed |
| 16 | 28504320 | Photosensitization Priming of Tumor Microenvironments Improves Delivery of Nanotherapeutics via Neutrophil Infiltration. | Adv Mater | 2017 | https://conductscience.org/library/papers/28504320 | PubMed |
| 17 | 28863460 | Big Data in Cardiovascular Disease. | Eur Heart J | 2017 | https://conductscience.org/library/papers/28863460 | PubMed |
| 18 | 15050096 | C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. | Med Hypotheses | 2004 | https://conductscience.org/library/papers/15050096 | PubMed |
| 19 | 22015921 | Perspectives and opportunities for nanomedicine in the management of atherosclerosis. | Nat Rev Drug Discov | 2011 | https://conductscience.org/library/papers/22015921 | PubMed |
| 20 | 28233802 | Targeting neoantigens to augment antitumour immunity. | Nat Rev Cancer | 2017 | https://conductscience.org/library/papers/28233802 | PubMed |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942844 | Cell Membrane-Coated Nanoparticles as Biomimetic Drug Delivery Systems: Design, Therapeutic Applications, and Translational Challenges. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942844 | PubMed |
| 42514880 | Biomimetic Cell Membrane-Based Drug Delivery Systems for Oral Diseases: Engineering Strategies, Targeting Mechanisms, and Translational Challenges. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514880 | PubMed |
| 42513198 | Mechanistic Insights into the Action of Histamine-Functionalized PLA Nanoparticles Loaded with 5-Fluorouracil Against Gastric Cancer Cells In Vitro. | Molecules | 2026 | https://conductscience.org/library/papers/42513198 | PubMed |
| 42465799 | M2 Macrophages Attenuate AQP2+ Collecting Duct Cell Apoptosis via the TRAF1-TRAF2 Complex to Suppress Randall's Plaque Formation. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/42465799 | PubMed |
| 42403545 | Delivery of TCM Monomers Using Blood Cell Membrane Coated Biomimetic Nanoparticles to Target CVD. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42403545 | PubMed |
| 42366709 | Nanocarrier-Based Gene Delivery Systems: Mechanisms, Clinical Translation, and Future Perspectives. | Biotechnol Bioeng | 2026 | https://conductscience.org/library/papers/42366709 | PubMed |
| 42079439 | Application and Advances of Cell Membrane-Coated Nanoparticles in Diabetic Wound Healing. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42079439 | PubMed |
| 41810466 | From bench to bedside: Unveiling the background and benefits of nanovaccines tested in clinics. | Asian J Pharm Sci | 2026 | https://conductscience.org/library/papers/41810466 | PubMed |
| 41732384 | T cell-inspired therapeutic delivery platforms: From nanomedicines to cell therapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41732384 | PubMed |
| 41491720 | Emerging nano-immunotherapeutic strategies achieve metastatic colorectal cancer precision therapy. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41491720 | PubMed |
| 41332501 | Engineering Biomimetic Nanoplatforms for Acute Lung Injury: From Mechanistic Insights to Translational Opportunities. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41332501 | PubMed |
| 41326632 | Enhancing pharmacokinetic properties of Chikusetsusaponin IVa via modification of polyethylenimine/poly(lactic-co-glycolic acid) nanoparticles for sustained drug delivery. | Sci Rep | 2025 | https://conductscience.org/library/papers/41326632 | PubMed |
| 40919375 | Biomimetic nanocarriers for the therapy and management of intestinal inflammations. | Int J Pharm X | 2025 | https://conductscience.org/library/papers/40919375 | PubMed |
| 40806481 | Combination Therapy Using Phytochemicals and PARP Inhibitors in Hybrid Nanocarriers: An Optimistic Approach for the Management of Colon Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806481 | PubMed |
| 40768051 | Influence of carboxymethyl chitosan chain length on its interaction with vitamin C and curcumin: molecular docking and molecular dynamic approach. | J Mol Model | 2025 | https://conductscience.org/library/papers/40768051 | PubMed |
| 40528159 | Targeting circulating tumor cell‒neutrophil interactions: nanoengineered strategies for inhibiting cancer metastasis. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40528159 | PubMed |
| 40232044 | Engineering the Immune Response to Biomaterials. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40232044 | PubMed |
| 39986440 | PhotoChem Interplays: Lighting the Way for Drug Delivery and Diagnosis. | Adv Drug Deliv Rev | 2025 | https://conductscience.org/library/papers/39986440 | PubMed |
| 39669990 | The past, present, and future of endoscopic management for biliary strictures: technological innovations and stent advancements. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39669990 | PubMed |
| 39600709 | Biomaterials' enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment. | Front Immunol | 2024 | https://conductscience.org/library/papers/39600709 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36925703
GET https://conductscience.org/api/papers/v1/36925703/references?page=2